Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,454.00    20.00 (0.45%)
Bid:
4,446.00
Ask:
4,450.00
Spread: 4.00 (0.09%)
Market Cap: £4.67b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Half Year Pre-Close Update

17 Jul 2014 07:00

RNS Number : 5485M
Computacenter PLC
17 July 2014
 



 

Computacenter plc

Trading Update - Overall trading ahead of last year and in line with expectations

 17th July 2014

 

Computacenter plc ("Computacenter" or the "Group"), the independent provider of IT infrastructure services that enables users is today providing an update on trading based on preliminary unaudited financial information for the six months ended 30 June 2014, in advance of the announcement of its interim results on Friday, 29 August 2014.

 

Group

Group revenue for the first half increased by 2% on an as reported basis and by 4% in constant currency. Group Services revenue increased by 3% on an as reported basis and by 5% in constant currency. Group Supply Chain revenue increased by 2% on an as reported basis and by 4% in constant currency.

 

UK

UK revenue grew by 14% in the first half of the year with Services revenue increasing by 8% and Supply Chain revenue increasing by 18%. We remain pleased with the continued strong performance in the UK business, particularly the Services growth. Whilst the Supply Chain revenue growth was not as strong in the second quarter as in the first, as expected, growth was still 9%. We have managed to secure a significant renewal of a major customer contract within our Contractual Services business in the second quarter and we are pleased to be at the exclusive stage, subject to contract, on a major new contract. We are also optimistic about our pipeline for the remainder of the year. 

 

Germany

German revenue fell by 10% in constant currency during the first half, with a 2% increase in Services revenue and 16% reduction in Supply Chain revenue. Whilst we are disappointed with the Supply Chain revenue reduction, a significant percentage of the reduction relates to one low margin software licence of circa £25 million sold in the second quarter of 2013 and not repeated this year. 

More significantly we are beginning to see some progress with our Services business in Germany. We are starting to deliver some new contract wins which is likely to increase the growth rate going forward. We are pleased with our Professional Services sales and our Services margin continues to improve. Our three onerous contracts continue to perform in line with the provision previously made for them. 

 

France

French revenue increased by 14% in constant currency in the first half of the year, with Services revenue increasing by 3% and Supply Chain revenue increasing by 17%. Whilst this Supply Chain revenue growth is flattered due to an extremely quiet June 2013, as we migrated to our Group ERP system, it is testament to the delivery of an improved customer experience and the fact that our systems issues in France are now behind us. However, gross margins have been challenging, particularly in Services.

We are uncompetitive in France and in order to improve long term profitability, we need to address our cost base. We expect to incur an exceptional restructuring charge of circa £9 million, which is at the top of the range previously announced in our April 2014 Interim Management Statement.

 

Financial Position

Group net funds excluding customer specific finance (CSF) increased by slightly over £30 million from £39 million to approximately £69 million.

The 30 June 2013 figure of £39 million provided above excludes the effect of the £75 million of cash returned to shareholders during 2013, £44 million of which was returned in July 2013, in order to show a like-for-like comparison against the cash position as at 30 June 2014.

 

Outlook

For the first half of 2014 Computacenter will show progress over the same period for last year. This has been delivered by a strong performance in the UK held back somewhat by the performance in France and Germany much of which was as expected.

We are confident that the momentum that we have in the UK will continue for the foreseeable future due to our P&L investment in organic growth and a strong pipeline. Whilst we have been somewhat surprised and disappointed by our Supply Chain performance in Germany so far this year, we are starting to see some real improvement in our Services prospects which is strategically more important. 

New management is now in place in our French business and we have rolled out the Group Operating Model but work needs to be done to create a profitable and sustainable business. 

We remain on track with the Board's expectations for 2014 and confident about the growth prospects for the long-term.

 

Enquiries:

Computacenter plc

Mike Norris, Chief Executive: 01707 631601

Tony Conophy, Finance Director: 01707 631515

 

Tulchan Communications

James Macey White 020 7353 4200

Christian Cowley

 

Conference call

There will be a conference call for analysts and investors this morning at 9.00am.

 

Appendix

Revenue growth summary by segment for Q2 2014 vs Q2 2013 and H1 2014 vs H1 2013

Change vs 2013

Q2 ChangeAs Reported

Q2 Change Constant Currency

H1 ChangeAs Reported

H1 Change Constant Currency

Supply Chain Revenue

UK

9%

9%

18%

18%

Germany

-27%

-25%

-18%

-16%

France

17%

21%

13%

17%

Group

-5%

-3%

2%

4%

Services Revenue

UK

9%

9%

8%

8%

Germany

-2%

1%

-2%

2%

France

9%

12%

0%

3%

Group

4%

6%

3%

5%

Total Revenue

UK

9%

9%

14%

14%

Germany

-19%

-16%

-13%

-10%

France

16%

20%

11%

14%

Group

-2%

0%

2%

4%

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXXKFFALEFF
Date   Source Headline
9th Dec 202212:00 pmRNSChange of Auditor
2nd Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSQ3 2022 Trading Update
20th Oct 202210:30 amRNSDirectorate Change
27th Sep 202212:00 pmRNSHolding(s) in Company
22nd Sep 202210:30 amRNSDirector/PDMR Shareholding
12th Sep 202212:00 pmRNSDirector/PDMR Shareholding
9th Sep 20227:00 amRNSHalf-year Report
5th Aug 20229:30 amRNSBlock listing Interim Review
13th Jul 20227:00 amRNSAcquisition
19th May 20221:30 pmRNSResult of AGM
9th May 20225:30 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSQ1 2022 Trading Update
27th Apr 20229:03 amRNSCarbon Neutral Announcement
13th Apr 202212:15 pmRNS2021 Annual Financial Report & Notice of 2022 AGM
23rd Mar 20224:45 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results 2021
7th Feb 20229:49 amRNSBlock listing Interim Review
24th Jan 20227:00 amRNSPre-Close Trading Statement
12th Jan 20229:45 amRNSHolding(s) in Company
14th Dec 20214:45 pmRNSHolding(s) in Company
13th Dec 20215:00 pmRNSHolding(s) in Company
10th Dec 20212:00 pmRNSCompany Secretary Change
2nd Dec 20212:45 pmRNSDirector/PDMR Shareholding
15th Nov 202112:15 pmRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSQ3 2021 Trading Update
30th Sep 202112:00 pmRNSDirectorate Change
15th Sep 20214:25 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSTrading Statement
12th Aug 202112:00 pmRNSDirector Declaration
6th Aug 202111:15 amRNSBlock listing Interim Review
21st Jul 20217:00 amRNSTrading Statement
20th May 20211:00 pmRNSResult of AGM
30th Apr 20217:00 amRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSQ1 2021 Trading Update
20th Apr 20217:00 amRNS2020 Annual Report & Notice of 2021 AGM
24th Mar 20212:00 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSFinal Results 2020
10th Mar 20217:00 amRNSDirectorate Change
5th Feb 20211:18 pmRNSBlock listing Interim Review
25th Jan 202111:45 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSPre-Close Trading Statement
4th Jan 20211:00 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSTrading Statement
10th Nov 20204:00 pmRNSPDMR/PCA Shareholding
30th Oct 20207:00 amRNSQ3 2020 Trading Update
27th Oct 20209:30 amRNSDirector/PDMR Shareholding
23rd Oct 20205:45 pmRNSApproval of Arrangement Agreement
16th Sep 202012:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.